Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Ho Chang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Psychiatry|April 29, 2003
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophreniaHsien-Yuan Lane, Yue-Cune Chang, Yiao-Cheung Cheng, et al.
Psychopharmacology|December 10, 2003
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinantsHsien-Yuan Lane, Yue-Cune Chang, Chih-Chiang Chiu, et al.
Journal of Clinical Psychopharmacology|January 12, 2005
Dopamine D3 receptor Ser9Gly polymorphism and risperidone responseHsien-Yuan Lane, Shih-Kuan Hsu, Yi-Ching Liu, et al.
Psychopharmacology|June 21, 2008
Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychoticsChing-Hua Lin, Ching-Wen Huang, Cheng-Chung Chen, et al.
The Journal of Clinical Psychiatry|September 15, 2007
Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic studyYa Mei Bai, Tzu Ting Chen, Jen-Yeu Chen, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Risperidone-related weight gain: genetic and nongenetic predictorsHsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, et al.
Journal of Clinical Psychopharmacology|May 16, 2007
Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injectionYa Mei Bai, Tzu Ting Chen, Wen Kuo Lin, et al.
Journal of Psychiatry & Neuroscience : JPN|January 17, 2008
Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adultsHsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, et al.
Journal of Clinical Pharmacology|November 17, 2004
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophreniaChih-Chiang Chiu, Hsien-Yuan Lane, Ming-Chyi Huang, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot studyHsien-Yuan Lane, Shi-Chin Guo, Tzung-Jeng Hwang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Clinical Psychiatry|April 29, 2003
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophreniaHsien-Yuan Lane, Yue-Cune Chang, Yiao-Cheung Cheng, et al.
Psychopharmacology|December 10, 2003
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinantsHsien-Yuan Lane, Yue-Cune Chang, Chih-Chiang Chiu, et al.
Journal of Clinical Psychopharmacology|January 12, 2005
Dopamine D3 receptor Ser9Gly polymorphism and risperidone responseHsien-Yuan Lane, Shih-Kuan Hsu, Yi-Ching Liu, et al.
Psychopharmacology|June 21, 2008
Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychoticsChing-Hua Lin, Ching-Wen Huang, Cheng-Chung Chen, et al.
The Journal of Clinical Psychiatry|September 15, 2007
Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic studyYa Mei Bai, Tzu Ting Chen, Jen-Yeu Chen, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Risperidone-related weight gain: genetic and nongenetic predictorsHsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, et al.
Journal of Clinical Psychopharmacology|May 16, 2007
Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injectionYa Mei Bai, Tzu Ting Chen, Wen Kuo Lin, et al.
Journal of Psychiatry & Neuroscience : JPN|January 17, 2008
Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adultsHsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, et al.
Journal of Clinical Pharmacology|November 17, 2004
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophreniaChih-Chiang Chiu, Hsien-Yuan Lane, Ming-Chyi Huang, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot studyHsien-Yuan Lane, Shi-Chin Guo, Tzung-Jeng Hwang, et al.
Pageof 2